SUGALIFE-M - Gliclazide 80mg + Metformin 500mg | Intralife Pharmaceuticals
DIASAGE
Premium

SUGALIFE-M

MRP: 850

Packaging: 10X10

Pack Type: tablet

Composition:

Gliclazide 80mg + Metformin 500mg

Indication:

Obese Type 2 Diabets , Secondary falure with su/Metformin, Moderate fo severe NIDDm, NiDDm with vascular complications

Description:

Gliclazide 80 mg + Metformin Hydrochloride 500 mg is a fixed-dose oral antidiabetic combination used to manage type 2 diabetes mellitus in adults. This dual therapy works via two complementary mechanisms:

  • Gliclazide, a sulfonylurea, stimulates insulin secretion from pancreatic beta cells, helping to reduce elevated blood glucose levels.

  • Metformin, a biguanide, decreases hepatic glucose production, improves insulin sensitivity, and enhances peripheral glucose uptake.

This combination is indicated in patients whose blood sugar levels are not adequately controlled with diet, exercise, or monotherapy. It helps control both fasting and postprandial blood sugar levels, providing better glycemic management and long-term diabetes control.

Tags:

Type 2 Diabetes Oral Antidiabetics Combination Therapy Sulfonylurea Biguanide (Metformin) Prescription Medicine
  • Dual mechanism improves glycemic control effectively
  • Lowers fasting and post-meal glucose levels
  • Reduces HbA1c more efficiently than monotherapy
  • May support cardiovascular risk reduction
  • Convenient oral dosing improves adherence

Usage Information

Dosage

Typical dose: One tablet once or twice daily, preferably with meals Follow the dosage prescribed by your healthcare provider Do not crush or chew the tablets Regular blood sugar monitoring is recommended

Side Effects

Hypoglycemia (more likely if meals are skipped or dose is too high) Gastrointestinal issues (nausea, diarrhea, bloating due to Metformin) Weight gain (due to Gliclazide in some patients) Headache or dizziness Rare: Lactic acidosis (Metformin-related, in renal impairment) Seek immediate medical attention for symptoms of low blood sugar or severe side effects.

Contraindications

Type 1 diabetes mellitus Diabetic ketoacidosis Severe renal or hepatic impairment Known allergy to Gliclazide, Metformin, or sulfonylureas Pregnancy or lactation (unless specifically advised by a doctor) Conditions predisposing to lactic acidosis (e.g., dehydration, severe infection)

Availability

Gliclazide 80 mg + Metformin 500 mg tablets Diabetes combination therapy Sulfonylurea with Metformin Type 2 diabetes dual treatment Oral antidiabetic medication Blood sugar control tablets Diabetes fixed-dose combo

Gliclazide 80mg + Metformin 500mg Tablets | Intralife Pharmaceuticals | Intralife